v3.26.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash flows from operating activities:    
Net loss $ (3,406) $ (11,136)
Adjustment to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 20 38
Stock-based compensation 381 101
Loss on issuance of the Lynrock Lake Term Loan 0 6,640
Debt modification expense 0 90
Loss on debt extinguishment 0 2,034
Non-cash interest 677 477
Non-cash operating lease (12) (9)
Change in fair value of warrant liability 173 705
Change in fair value of derivative liability 0 (101)
Change in fair value of earnout liability (50) 50
Changes in operating assets and liabilities:    
Accounts receivable (572) (2,715)
Inventory (1,799) 268
Prepaid expenses and other current assets (247) (635)
Accounts payable (495) 61
Accrued expenses and other current liabilities 468 461
Other liabilities 1,208 135
Net cash used in operating activities (3,654) (3,536)
Cash flows from investing activities:    
Purchases of property and equipment (17) 0
Net cash used in investing activities (17) 0
Cash flows from financing activities:    
Proceeds from sale of common stock and warrants 155 0
Proceeds from long-term debt, net of issuance costs 0 10,000
Repayment of long-term debt (9) (4,648)
Cash paid for stock issuance costs (232) 0
Proceeds from stock option exercises 245 0
Net cash provided by financing activities 159 5,352
Net increase in cash and cash equivalents and restricted cash and cash equivalents (3,512) 1,816
Cash and cash equivalents and restricted cash and cash equivalents, beginning balance 10,462 1,192
Cash and cash equivalents and restricted cash and cash equivalents, ending balance 6,950 3,008
Supplemental disclosure of cash flow information:    
Cash paid for interest 0 12
Supplemental disclosures of noncash investing and financing activities:    
Purchase of property and equipment included in accounts payable 0 6
Debt issuance costs included in accrued expenses 0 144
Unpaid issuance costs included in accounts payable and accrued expenses and other current liabilities related to the sale of common stock and warrants 74 0
Conversion of accrued interest into common stock $ 0 $ 174